Healthy Living/WellnessIs Novartis' LCZ696 the next gold standard of heart failure drugs? Following the impressive results of the PARADIGM-HF study, some already speculate on the possibility of Novartis' LCZ696 becoming the next gold standard of treatment for heart failure.by Rhodi Lee
Healthy Living/WellnessEarly trial results of heart drug suggests Novartis has a winner on its handsby Tabitha Laffernis
